Abbreviations used in this paper: FERM, band 4.1/ezrin/radixin/moesin-like; ITC, isothermal titration calorimetry; PI(4,5)P~2~, phosphatidylinositol-(4,5)-bisphosphate; PIPKIγ, phosphatidylinositol-(4)-phosphate 5-kinase type Iγ.

Introduction
============

In order for neurotransmitter release to continue reliably, neurotransmitter-containing synaptic vesicles must be rapidly and locally recycled. One predominant mechanism for their recycling involves clathrin-mediated endocytosis, a process that occurs at the periphery of active zones of secretion within an actin-rich region called the "periactive," or endocytic, zone ([@bib29]; [@bib34]). Clathrin-mediated synaptic vesicle recycling requires intrinsic coat proteins and accessory factors, including actin regulatory proteins, as well as the interactions of these proteins with phosphatidylinositol-(4,5)-bisphosphate \[PI(4,5)P~2~\], a phosphoinositide concentrated in the plasma membrane ([@bib33]; [@bib26]).

Because PI(4,5)P~2~ participates in both clathrin coat and actin nucleation, it is important to identify how the presynaptic pool of PI(4,5)P~2~ is generated and maintained ([@bib36]). Two enzymes concentrated at synapses, phosphatidylinositol-(4)-phosphate 5-kinase type Iγ (PIPKIγ) and the polyphosphoinositide phosphatase synaptojanin, synthesize and degrade, respectively, a large fraction of the presynaptic pool of PI(4,5)P~2~ ([@bib24]; [@bib8]; [@bib15]; [@bib17]; [@bib37]; [@bib35]; [@bib12]). Membrane recruitment and enzymatic activity of PIPKIγ are regulated by interactions with its membrane-localized binding partners, Rho family and Arf6 GTPases ([@bib18]; [@bib20]). In addition, the predominant splice variants of PIPKIγ expressed in brain contain a unique 28-aa COOH-terminal extension that interacts with the focal adhesion protein talin ([@bib11]; [@bib22]; [@bib16]). Although talin is present together with PIPKIγ at synapses, its function either pre- or post-synaptically is unknown. The interaction of talin with PIPKIγ is likely to be very important because it greatly up-regulates the catalytic activity of PIPKIγ in vitro ([@bib11]).

Talin is an adaptor between integrins and actin that mediates bi-directional integrin signaling at cell adhesion sites ([@bib5]; [@bib9]; [@bib4]). The two highly homologous talin isoforms (talin 1 and 2) comprise a 47-kD NH~2~-terminal globular head and a 190-kD COOH-terminal rodlike tail. The tail has multiple binding sites for actin and vinculin, and the head contains a band 4.1/ezrin/radixin/moesin-like (FERM) domain that binds β-integrins, actin, and PI(4,5)P~2~ ([@bib5]; [@bib11]; [@bib22]). The FERM domain also contains the PIPKIγ binding site, which overlaps with the integrin binding site. These two interactions are mutually exclusive and competitive ([@bib1]; [@bib6]). Thus, a dynamic cycle has been proposed in which talin first recruits PIPKIγ to the membrane to generate PI(4,5)P~2~, and then upon binding PI(4,5)P~2~, shifts to integrin ([@bib1]; [@bib23]; [@bib6]). Because talin exists as an antiparallel homodimer, another possibility is that the dimer simultaneously binds both PIPKIγ and integrin. Perturbation of these interactions in fibroblasts disrupts actin and causes cell detachment ([@bib11]; [@bib22]).

At synapses, talin may participate in the recruitment of PIPKIγ to the membrane in order to generate the PI(4,5)P~2~ pool involved in clathrin coat and actin dynamics during vesicle recycling ([@bib12]). The lamprey reticulospinal synapses provide a tractable model to examine this question because of the prominence of the actin surrounding the large vesicle clusters ([@bib15]; [@bib32]; [@bib2]). Here, we capitalize on the unique features of these synapses to demonstrate that perturbing talin function and, more specifically, perturbing its interactions at the PIP kinase binding site, drastically affects both actin dynamics and synaptic vesicle endocytosis. These results demonstrate that talin functions presynaptically within a protein network that links phosphoinositide metabolism to actin and clathrin coat dynamics.

Results and discussion
======================

The talin interaction with a PIP kinase is conserved in lamprey
---------------------------------------------------------------

In Western blots of rat brain protein extracts, talin immunoreactivity migrates as a 230-kD band ([Fig. 1](#fig1){ref-type="fig"} A) and a 190-kD proteolytic fragment lacking the head domain ([@bib3]; [Fig. 1](#fig1){ref-type="fig"} A). Affinity chromatography using a GST fusion protein of the 28-aa COOH-terminal tail of human PIPKIγ (GST-PIPKIγ tail) resulted in the purification of the upper talin band, as expected ([Fig. 1](#fig1){ref-type="fig"} A; [@bib11]). The proteolytic fragment, which lacks the PIPKIγ binding site, remained in the supernatant. Talin was the only major band retained by GST-PIPKIγ tail, as shown by Coomassie blue staining of the affinity-purified material ([Fig. 1](#fig1){ref-type="fig"} B). Similarly, anti-talin antibodies recognized two proteins in lamprey spinal cord extracts of the appropriate size for talin and its proteolytic fragment ([Fig. 1](#fig1){ref-type="fig"} C), and the larger protein, which corresponded to a major band visible by Coomassie blue ([Fig. 1](#fig1){ref-type="fig"} D), was pulled down by GST-PIPKIγ tail. Western blots of lamprey extracts with an anti-PIPKIγ antibody raised against the 28-aa COOH-terminal tail revealed a 90-kD protein doublet that was affinity purified by a GST fusion protein of human talin head (GST-talin head; [Fig. 1](#fig1){ref-type="fig"} E). Immunoprecipitates generated by this PIPKIγ antibody from lamprey extracts contained a much higher PIP~2~-synthesizing activity than did the control, as demonstrated by TLC separation of ^32^P-labeled phosphoinositides generated by in vitro incubation with brain lipids and γ-\[^32^P\] ATP ([Fig. 1](#fig1){ref-type="fig"} F). Further, using anti-talin antibodies, PIPKIγ was coimmunoprecipitated from both rat brain ([Fig. 1](#fig1){ref-type="fig"} G, middle lane) and lamprey extracts ([Fig. 1](#fig1){ref-type="fig"} H, left lane) ([@bib11]). Thus, lamprey contains a PIP kinase that interacts with talin. Immunostaining of lamprey spinal cord cross sections demonstrated that talin is concentrated at synapses, including those of the large reticulospinal axons, as shown by its colocalization with the synaptic protein synapsin ([Fig. 1](#fig1){ref-type="fig"} I) ([@bib10]; [@bib27]).

![**Interaction of PIPK with talin and synaptic localization of talin in the lamprey spinal cord.** (A) Western blot with an anti-talin antibody of rat brain extract (load) and the material affinity purified from such extract by either GST or GST-PIPKIγ tail in pull-down experiments (S, supernatant; P, pellet). The top talin band is pulled down selectively by GST-PIPKIγ tail. (B) Coomassie blue--stained protein gel of a pull-down with GST-PIPKIγ tail from rat brain extracts (ext.) showing specificity of the talin--PIPKIγ interaction. (C) Western blot with an anti-talin antibody of lamprey extract (load) and of the material purified by either GST or GST-PIPKIγ tail. (D) Coomassie blue--stained protein gel of a pull-down with GST-PIPKIγ tail from lamprey spinal cord extracts. (E) Western blot with an anti-PIPKIγ antibody of lamprey extract (load) and of the material purified by either GST or GST-talin head. The 90-kD doublet is specifically affinity purified by GST-talin head. (F) TLC demonstrating the generation of phosphoinositides from lamprey extracts by immunoprecipitates of PIPKIγ antibody (α-PIPK IP) or control IgGs (ctrl IgGs). Note the prominent \[^32^P\]PIP~2~ band produced by the α-PIPK IP. (G, top panels) Western blots of anti-talin immunoprecipitates from rat brain extracts showing that coprecipitation of PIPKIγ ("α-talin IP" lane) is prevented by PIPK pep but not mutant PIPK pep (100 μM). (G, bottom panels) TLC and quantification of \[^32^P\]PIP~2~ showing correlation between PIPKIγ coprecipitation and PIP~2~-synthesizing activity. (cpm, counts per minute). (H) Western blot of anti-talin immunoprecipitates from lamprey spinal cord extracts showing that the PIPK pep (300 μM) prevents coprecipitation of PIPK. (I) Double immunofluorescence of cross sections of lamprey spinal cord stained for talin (red) and for the presynaptic marker, synapsin (green). Arrows indicate synapses in the neuropil. Asterisks indicate reticulospinal axons. Note the colocalization of talin with synapsin at the reticulospinal synapses (insets).](200406020f1){#fig1}

A PIPKIγ peptide inhibits the interaction of a PIP kinase with talin in lamprey
-------------------------------------------------------------------------------

Next, we characterized a 14-mer PIPK peptide (PIPK pep) centered around the minimal talin-binding site in human PIPKIγ, WVYSPL ([Fig. 2](#fig2){ref-type="fig"} A; [@bib11]). Pre-incubation of rat brain extracts with PIPK pep nearly completely abolished the ability of anti-talin antibodies to coprecipitate PIP kinase both from rat brain ([Fig. 1](#fig1){ref-type="fig"} G, fourth lane) and lamprey spinal cord extracts ([Fig. 1](#fig1){ref-type="fig"} H; right lane). In contrast, a mutant PIPK peptide (Mut PIPK pep; [Fig. 2](#fig2){ref-type="fig"} A) in which the critical tryptophan was replaced by an alanine had negligible effects ([Fig. 1](#fig1){ref-type="fig"} G, fifth lane). Isothermal titration calorimetry (ITC) revealed that PIPK pep binds to the head of talin in a saturable manner ([Fig. 2, B and C](#fig2){ref-type="fig"}) with a K~D~ of 0.65 μM, as determined by fitting to a nonlinear least squares function. This value is roughly in agreement with previous measurements made by nuclear magnetic resonance spectroscopy using a slightly longer PIPKIγ peptide ([@bib1]). Mut PIPK pep demonstrated only negligible binding to talin head ([Fig. 2, D and E](#fig2){ref-type="fig"}).

![**Binding of a PIPK peptide to talin head.** (A) Diagram showing the domain structure of human PIPKIγ and the sequences of the PIPK peptides. Underlined residues indicate the talin binding region. (B--E) ITC traces showing the responses when either PIPK pep (B) or Mutant PIPK pep (D) was injected (arrow) into a chamber containing talin head (Tal H). Decreased magnitude of the response indicates talin saturation by PIPK pep. Dose--response curves show that PIPK pep (C), but not Mutant PIPK pep (E), binds to talin head. Data points were derived from B and D and were fit with a nonlinear least squares function (solid line).](200406020f2){#fig2}

PIPK peptide inhibits the accumulation of actin at periactive zones
-------------------------------------------------------------------

Lamprey reticulospinal axons form en passant synapses with motor neurons. The large vesicle clusters at these synapses are surrounded by a ring of actin at periactive zones that can be visualized by the microinjection of fluorescently labeled phalloidin ([Fig. 3](#fig3){ref-type="fig"} A) ([@bib32]). To determine whether the talin--PIPK interaction regulates this pool of synaptic actin, individual lamprey axons were first microinjected with rhodamine-conjugated Mut PIPK pep or PIPK pep (red), and immediately after with Alexa 488--phalloidin (green). Although the Mut PIPK peptide did not affect the accumulation of phalloidin fluorescence at synapses, PIPK peptide strongly inhibited this accumulation ([Fig. 3, B and C](#fig3){ref-type="fig"}). The PIPK peptide caused an average 64% reduction in the synaptic phalloidin fluorescence at intra-axonal concentrations \>10 μM, which is within the range expected to compete the talin--PIPK interaction ([Fig. 3](#fig3){ref-type="fig"} D). This effect is likely an underestimation because the intensity of synaptic phalloidin fluorescence at sites of highest PIPK peptide concentration was often at the limit of detectability, and therefore was not measured. Even at concentrations as high as 200--700 μM, Mut PIPK peptide had no effect on synaptic phalloidin fluorescence ([Fig. 3](#fig3){ref-type="fig"} D).

![**Microinjection of PIPK pep disrupts the actin cytoskeleton at synapses.** (A) Confocal image of a lamprey reticulospinal axon injected with Alexa 488--phalloidin (green). Thin, white line denotes axonal border. Phalloidin labels rings of actin at periactive zones of synapses, as indicated by the cartoon (SV, synaptic vesicle). (B and C) Images of axons injected with rhodamine-conjugated (red) Mut PIPK pep or PIPK pep and then with Alexa 488--phalloidin at sites indicated by white asterisks. Although Mut PIPK pep had no effect (B), the fluorescence intensity of phalloidin rings is greatly diminished by PIPK pep (C). Bars, 20 μm. (D) Average fluorescence intensity of the phalloidin rings over several concentration ranges of PIPK peptides as compared with that in the absence of any peptides (Control). Data indicate mean values and SEM from synapses in 31 control, 15 PIPK pep--injected, and 14 Mut PIPK pep--injected axons. Asterisks indicate statistical significance as compared with control (for PIPK pep 10--100 μM, P \< 0.05 × 10^−13^; for PIPK pep 200--700 μM, P \< 0.05 × 10^−8^; *t* test).](200406020f3){#fig3}

The decreased accumulation of synaptic actin observed upon PIPK peptide injection may result from reduced PI(4,5)P~2~ levels as a consequence of impairing talin-mediated PIP kinase recruitment to the membrane. Additional effects of PIPK peptide on actin may be produced by a perturbation of the talin--integrin interaction, although this remains to be explored. Consistent with the results reported here, microinjection of antibodies directed against the PI(4,5)P~2~ phosphatase synaptojanin (e.g., a treatment that is expected to increase PI(4,5)P~2~) produced the opposite effect, which was a hypertrophy of perisynaptic actin at lamprey synapses ([@bib15]).

PIPK peptide perturbs clathrin-mediated endocytosis
---------------------------------------------------

Next, we examined the effect of PIPK peptide on synaptic vesicle trafficking using EM. Axons were microinjected with either PIPK or mutant peptide, stimulated (20 Hz for 5 min) to induce exocytosis and compensatory synaptic vesicle recycling, and then fixed ([@bib27]). Electron micrographs of synapses within mutant PIPK peptide--injected axons revealed the typical large synaptic vesicle clusters and very few clathrin-coated pits ([Fig. 4](#fig4){ref-type="fig"} A). Under these stimulation conditions, synaptic vesicle recycling is very efficient in control synapses. In contrast, images of synapses from PIPK peptide--injected axons revealed numerous clathrin-coated pits and large folds of the plasma membrane at periactive zones that often extended toward the postsynaptic cell ([Fig. 4, B and C](#fig4){ref-type="fig"}). In addition, the average number of synaptic vesicles per synapse in PIPK peptide--injected axons was 33% smaller than in mutant PIPK peptide--injected control axons, indicating that synaptic vesicle recycling was perturbed ([Fig. 4](#fig4){ref-type="fig"} D; P \< 0.05; *t* test). A measurement of the plasma membrane cross-sectional profile within a 1-μm radial distance from the outer edge of the active zone revealed a twofold increase in length relative to mutant PIPK pep, denoting a striking expansion of the plasma membrane ([Fig. 4](#fig4){ref-type="fig"} E; P \< 0.05 × 10^−6^; *t* test). Further, the total number of clathrin-coated profiles per synapse dramatically increased 10-fold in the presence of PIPK pep ([Fig. 4](#fig4){ref-type="fig"} F; P \< 0.05 × 10^−8^; *t* test). When the coated profiles were staged according to state of maturation, the greatest increase was observed in unconstricted coated pits ([Fig. 4](#fig4){ref-type="fig"} G).

![**Ultrastructural changes produced by PIPK pep at lamprey synapses.** (A and B) Electron micrographs of stimulated synapses after axonal injection of either Mut PIPK pep or PIPK pep. In the presence of the Mut PIPK pep (A), only few coated pits are observed. In contrast, numerous clathrin-coated pits (red circles) and large plasma membrane foldings (arrows) are observed in the presence of PIPK pep (B). (C) Gallery showing unconstricted clathrin-coated pits at periactive zones of synapses within PIPK pep--injected axons. Bars, 0.2 μm. (D--G) Quantification of the number of synaptic vesicles (D, SVs), the plasma membrane (PM) cross-sectional profile (E), the total number of clathrin-coated profiles (F), and the percentages of coated profiles at various stages of maturation (G) per synapse. Data represent mean values and SEM for 21 synapses from 2 axons injected with PIPK pep and 20 synapses from 2 axons injected with Mutant PIPK pep.](200406020f4){#fig4}

To further assess the specificity of the effects on synaptic vesicle recycling, we injected GST-talin head. This reagent is expected to compete the interactions of the FERM domain of endogenous talin with its binding partners. Electron micrographs of stimulated synapses within axons injected with GST-talin head revealed a perturbation of clathrin-mediated endocytosis at synapses similar to that observed with PIPK pep ([Fig. 5](#fig5){ref-type="fig"}). Compared with GST controls, GST-talin head caused an increase in the length of the plasma membrane cross-sectional profile around synapses ([Fig. 5, A, B, and E](#fig5){ref-type="fig"}; P \< 0.05 *t* test), and a twofold increase in the number of clathrin-coated profiles ([Fig. 5](#fig5){ref-type="fig"} F). Like the PIPK peptide, GST-talin head specifically increased the number of unconstricted coated pits ([Fig. 5, B, C, and G](#fig5){ref-type="fig"}; P \< 0.05 *t* test), further supporting a presynaptic role for talin in coated vesicle maturation. Only a modest, nonstatistically significant decrease in the number of synaptic vesicles was observed in the presence of GST-talin head ([Fig. 5](#fig5){ref-type="fig"} D). The less dramatic phenotype observed with GST-talin head, rather than with the PIPK peptide, likely reflects the lower axonal concentration that was achieved by microinjection of this fusion protein, which was estimated to be in the range of 0.5--2.5 μM (i.e., in the same range of the K~D~ of the talin--PIPK interaction). However, the similarity to the PIPK peptide phenotype indicates that GST-talin head targeted the same process.

![**Ultrastructural changes produced by talin head at lamprey synapses.** (A and B) Electron micrographs of stimulated synapses after axonal injection of either GST or GST-talin head. In the presence of GST (A), only few coated pits are observed. In contrast, more clathrin-coated pits (red circles) and large membrane foldings (arrows) are observed in the presence of GST-talin head (B). (C) Gallery showing unconstricted clathrin-coated pits in periactive zones within GST-talin head--injected axons. Bars, 0.2 μm. (D--G) Quantification of the number of SVs (D), the PM cross-sectional profile (E), the total number of clathrin-coated profiles (F), and percentages of coated profiles at various stages of maturation (G) per synapse cross section. Data represent mean values and SEM of 10 synapses from 4 axons injected with GST controls and 11 synapses from 4 axons injected with GST-talin head.](200406020f5){#fig5}

The ultrastructural changes produced by the microinjection of both the PIPK peptide and the GST-talin head indicate a kinetic delay or an arrest of the clathrin-mediated endocytic reaction. The increased number of coated pits may seem at odds with the role of PI(4,5)P~2~ in nucleating clathrin coat formation ([@bib36]). However, partial recruitment of PIPKIγ to the plasma membrane may occur by alternate mechanisms even when the interaction with talin is prevented. For example, PIPKIγ recruitment may occur via interactions with Rho family or Arf6 GTPases ([@bib7]; [@bib18]; [@bib20]). Given that the PIP kinase interactions with Arf6 and Rho occur outside the talin-binding region (because the interactions are conserved amongst all type I PIP kinase isoforms), it is unlikely that our reagents altered recruitment by these GTPases ([@bib13]). Thus, the recruitment of PIPKIγ by small GTPases may produce sufficient amounts of PI(4,5)P~2~ for clathrin coat nucleation by the clathrin adaptors. Other PI(4) 5-kinases may also come into play. Furthermore, accumulation of clathrin-coated pits could occur in the presence of lower PI(4,5)P~2~ levels if coat maturation was delayed.

Strikingly, the majority of clathrin-coated pits observed at PIPK peptide--treated synapses have a wide neck, reflecting a defect at an early stage of endocytosis. A similar accumulation of unconstricted clathrin-coated pits was observed at these synapses after treatment with actin-disrupting toxins ([@bib32]). Thus, our experiments seem to have perturbed regulatory mechanisms at the interface between endocytosis and actin ([@bib28]; [@bib14]). We note that dynamin, a GTPase critically implicated in the fission of endocytic vesicles, is thought to function as an actin regulatory protein ([@bib21]; [@bib30]). Dynamin\'s recruitment to endocytic intermediates and its activity are regulated in part by its interaction with PI(4,5)P~2~ ([@bib31]). Talin may affect a PI(4,5)P~2~ pool specifically involved in an actin-dependent maturation of endocytic intermediates.

A conclusion of our work is that talin participates in the biology of periactive zones of synapses by regulating actin and clathrin coat dynamics. Although it cannot be completely excluded that some of the PIPK peptide effects may result from perturbing interactors other than talin, in vitro binding experiments have shown that talin is by far the major binding partner of PIPKIγ ([Fig. 1](#fig1){ref-type="fig"} C; [@bib11]). Furthermore, the fact that talin head produces a phenotype on vesicle trafficking similar to that of the PIPK peptide supports the hypothesis that PIPKIγ acts primarily by disrupting talin function. The prominent effects of the PIPK peptide on both actin and clathrin-mediated endocytosis in our work provides further evidence for a close functional link between these processes ([@bib25]; [@bib32]; [@bib19]). Accordingly, a number of possible molecular links between actin and clathrin-mediated endocytosis, which include Hip/Hip1R, dynamin, intersectin, PACSIN/syndapin, tuba, and cortactin, have been described previously ([@bib28]; [@bib14]).

These results extend our knowledge of the importance of phosphoinositide metabolism and actin polymerization during vesicle trafficking at the synapse and establish a role for talin in coordinating these processes. Further, our results suggest that synapses share mechanisms to coordinate membrane--cytoskeletal dynamics in common with other sites of cell adhesion.

Materials and methods
=====================

Protein and lipid biochemistry
------------------------------

Human PIPKIγ tail (aa 635--662) and human talin 2 head (aa 1--438) were expressed as GST fusion proteins and purified using a standard protocol. Affinity chromatography, immunoprecipitation, and TLC experiments were performed as described previously ([@bib37]; [@bib11]).

Rhodamine-conjugated PIPK peptide and mutant PIPK peptide were synthesized at the W.M. Keck Foundation Biotechnology Resource Laboratory (Yale University, New Haven, CT). The anti-talin antibody (TD77) used for detecting talin from GST pulldowns and with immunofluorescence was purchased from CHEMICON International, Inc. Anti-synapsin antibody was provided by Dr. Ona Bloom (Yale University, New Haven, CT). Anti--human talin 2 used for IPs and anti-PIPKIγ antibodies were generated in the De Camilli laboratory.

ITC
---

Peptides (300 μM) were repeatedly delivered (6 μl/injection; 23°C) into an ITC chamber containing 11 μM GST-talin head. The heat generated by each injection was measured and then analyzed with an ITC version of Microcal Origin 5.0 using embedded nonlinear least squares fitting routines. ITC experiments were performed at the Biophysics Resource of the W.M. Keck Foundation Biotechnology Resource Laboratory.

Imaging
-------

Adult lampreys (*Ichthyomyzon unicuspis*) were anaesthetized with tricaine methanesulfonate (0.1 g/l tank water). A spinal cord segment was removed and transferred ventral side up to a chamber containing ice-cold, oxygenated ringer (mM): 91 NaCl, 2.1 KCl, 2.6 CaCl~2~, 1.8 MgCl~2~, 4.0 glucose, and 2.0 Hepes-KOH, pH 7.4. Ventral orientation permits easy access to the large diameter (20--100 μm) reticulospinal axons.

Fluorescent reagents were diluted with lamprey internal solution (180 mM KCl and 10 mM Hepes-KOH, pH 7.4), loaded into glass microelectrodes, and then injected into several reticulospinal axons maintained at 10--15°C using N~2~ pulses delivered by a General Valve Picospritzer (10--100 psi; 10--200 ms; 0.3--1.0 Hz). Fluorescence was visualized with a microscope (Axioskop 2FS; Carl Zeiss MicroImaging, Inc.) using 10 and 40× water-immersion objectives. Images were acquired with a CCD camera (Photometrics Cascade 650; Roper Scientific) and analyzed with Metamorph software (Universal Imaging Corp.).

To quantify the PIPK peptide effect on actin, images of Alexa 488--phalloidin (Molecular Probes, Inc.) rings were taken at 40×. The axonal background fluorescence was subtracted and then divided from the synaptic fluorescence value in order to normalize for differences in amounts of injected phalloidin. All synapses within a 60-μm segment centered at the injection site were analyzed and then an averaged for each axon. Peptide concentration was measured by comparing the average rhodamine intensity within the 60-μm segment to a calibration curve.

EM
--

Reagents were injected into single axons nearest the spinal cord central canal. Bright field and fluorescence images were made for later identification of the injected axon. The axon was then stimulated intracellularly by action potentials using depolarizing pulses (1 ms; 30--100 nA; 20 Hz, 5 min), which were delivered via an Axoclamp 2B amplifier (Axon Instruments). Preparations were fixed overnight (3% glutaraldehyde, 1% formaldehyde, and 0.1% phosphate buffer; pH 7.4), processed for EM as described in [@bib27], and imaged (28,500×) using a microscope (model CM10; Philips).

To measure the cross-sectional profile of the plasma membrane, a straight line was drawn between the outer edge of the active zone and a point on the plasma membrane located 1 μm away. The curved profile of the plasma membrane between these two points was measured and then divided by the straight distance.
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